Descartes’ famous phrase “I think, therefore I am” (cogito, ergo sum) has been the subject of immense discussion in modern and contemporary philosophy. Is it an inference or a performance (Hintikka)?

Cartesian Therapeutics updates on Descartes-08 trials in myasthenia gravis and lupus, with financial results highlighting $182.1 million in cash. Cartesian Therapeutics, Inc. has announced the ...

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Want to stay on top of ...

Phase 3 trial of Descartes-08 in myasthenia gravis to start in 1H25 Cartesian Therapeutics has secured an agreement from the US Food and Drug Administration (FDA) under the Special Protocol Assessment ...

Cartesian Therapeutics has claimed a phase 2b win for its BCMA-directed CAR-T therapy in generalized myasthenia gravis (gMG). But the biotech’s victory came on a primary endpoint it changed in May and ...

Cartesian is among the leaders in a push by drugmakers to develop cell therapies for autoimmune conditions. Like Kyverna Therapeutics, Cabaletta Bio and many others, the company aims to show that a ...

A fascinating new paper from scientists at the AI research nonprofit LAION finds that even the most sophisticated large language models (LLMs) are frequently stumped by the same simple logic question ...

Moving an object from one location to another—picking and placing—is an ideal application for industrial robots due to the robots’ repeatability, throughput and favorable return on investment. It is ...